Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel et al. · New England Journal of Medicine · 2006 · 2.6K citations · Full text

Medicine, Gynecology, Oncology +14

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

Timothy M. Browder, Catherine Butterfield, Birgit M. Kräling et al. · PubMed · 2000 · 1.6K citations

Medicine, Oncology, Pharmacology +16

Development of a syngeneic mouse model for events related to ovarian cancer

Katherine F. Roby, Christopher Taylor, J. P. Sweetwood et al. · Carcinogenesis · 2000 · 597 citations · Full text

Veterinary Medicine, Cell Biology, Oncology +16

Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.

Guido Bocci, K. C. Nicolaou, Robert S. Kerbel · PubMed · 2002 · 445 citations

Medicine, Oncology, Pharmacology +16

Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer

Maha Saad, Olga B. Garbuzenko, Tamara Minko · Nanomedicine · 2008 · 367 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17